Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9594 posts found.

Healing the fracture in the system: the case for universal fraction liaison services access

November 28, 2025 Medical Communications, Research and Development Osteoporosis

By Tina Backhouse In 2024, the UK government committed to achieving 100% coverage of Fracture Liaison Services (FLS)across the NHS …
Feature

Celltrion’s Remsima IV approved by EC in liquid form

November 27, 2025 Research and Development Celltrion Inc, Immunology

Celltrion’s Remsima IV, the first-ever liquid formulation of infliximab for autoimmune diseases, has been approved by the European Commission (EC). …
News

One-carbon Therapeutics starts new cancer therapy trial

November 27, 2025 Research and Development Oncology, One-carbon Therapeutics

Clinical-stage biotechnology company One-carbon Therapeutics has announced that the first subject has been dosed in its clinical trial for TH9619, …
News

InnotiveDx gets £1m grant to advance UTI diagnostics system

November 27, 2025 Research and Development Diagnostics, InnotiveDx, Urology

InnotiveDx has announced that it has received a £1m grant from Pathways to Antimicrobial Clinical Efficacy (PACE) to advance the …
News

Accession Therapeutics doses first patient in new cancer immunotherapy trial

November 26, 2025 Research and Development Accession Therapeutics, Oncology

Biopharmaceutical company Accession Therapeutics has announced the dosing of the first patient in the phase 1 clinical trial of TROCEPT-01 …
News
Press release

Alvotech biosimilar receives EC marketing approval

November 26, 2025 Research and Development Alvotech, Immunology, Inflammatory disease, Rheumatology

The European Commission (EC) has granted marketing authorisation for Gobivaz, Alvotech’s first-in-market biosimilar of Simponi (golimumab), which is used for …
News
drug-trials

BioNet receives positive EMA opinion on new pertussis vaccine

November 19, 2025 Research and Development BioNet, Vaccine

BioNet has received a positive opinion from the Committee for Medicinal Products for Human Use of the European Medicines Agency …
News

1nhaler receives £1.5m in funding to develop new cardboard inhaler

November 19, 2025 Research and Development 1nhaler, asthma

1nhaler, a Scotland-based developer of drug delivery devices, has received £1.5m in seed funding for the development of its new …
News
brain_anatomy_medical_head_skull_digital_3_d_x_ray_xray_psychedelic_3720x2631

Study finds at-home brain stimulation therapies reduce depression relapse rate

November 14, 2025 Research and Development Brain Stimulation Therapies, Flow Neuroscience, Transcranial Direct Current Stimulation Therapy, depression

A new study published in the Journal of Affective Disorders has found that home-based, transcranial, direct current stimulation (tDCS) therapy, …
News

EVerZom enters research and licensing agreement with GENFIT

November 13, 2025 Research and Development EVerZom, Eviv, GENFIT, Liver Diseases, collaboration, licensing agreement

EVerZom, a French biotech company developing exosome-based therapies for regenerative medicine, has entered into a research and licensing agreement with …
News
drug-trials

University of Birmingham scientists develop new MRI contrast agent

November 12, 2025 Research and Development Diagnostics, MRI, University of Birmingham, medical imaging

Researchers at the University of Birmingham, UK, have developed a new class of magnetic resonance imaging (MRI) contrast agents that …
News

Novartis receives SMC approval for early breast cancer treatment

November 11, 2025 Research and Development Novartis, Scottish Medicines Consortium, breast cancer, nhs scotland

Novartis has announced that its treatment for early breast cancer, Kisqali (ribociclib), has received approval for use within NHS Scotland …
News

Vesper Bio reports positive topline results for dementia candidate

November 7, 2025 Research and Development Frontotemporal degeneration, Vesper Bio, clinical trials, dementia

Vesper Bio, a clinical-stage biotech developing novel oral therapies for neurodegenerative and neuropsychiatric disorders, has reported positive topline data from …
News

AAX Biotech and ToxoTech partner to develop next-gen biotherapeutics for neurological disorders

November 7, 2025 Research and Development AAX Biotech, Biotherapeutics, ToxoTech, neurological disorders

AAX Biotech, a biotech company specialising in next-generation antibody therapeutics, has entered a strategic partnership with ToxoTech, a biopharma company …
News

Von Willebrand disease – increasing awareness and access to vital care

November 4, 2025 Medical Communications, Research and Development European Medicines Association, Haematology, Takeda, Von Willebrand Disease, clinical trials, disease awareness

Pharmafile talks to Anthea Cherednichenko, Vice President Franchise Head Haematology and Transplant at Takeda about Von Willebrand disease, its causes …
Feature
The Gateway to Local Adoption Series

Latest content

BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer

February 5, 2026

AstronauTx appoints Adam Rosenberg as Chair of the Board

February 5, 2026

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026